Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,371 Crohns Disease
clinical trials

Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facey Medical Foundation (Parent)
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Bayside Clinical Research
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
NSB Research
mi
from
New Smyrna Beach, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
DM Clinical Research
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Palo Alto Center-Palo Alto Medical Foundation Research Institute
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Summit Clinical Research, LLC
mi
from
Petersburg, VA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Theia Clinical Research
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Ygenics
mi
from
Plano, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
San Antonio Gastroenterology
mi
from
San Antonio, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Digestive Disease Consultants - Southlake
mi
from
Southlake, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Medical Research, LLC
mi
from
Warren, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
New Hope Research Development
mi
from
West Covina, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Evansville, IN
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Ogden, UT
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Topeka, KS
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling, Phase III
Updated: 12/31/1969
Inquest Clinical Research/Coastal Gastroenterology Associates, PA
mi
from
Baytown, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling, Phase III
Updated: 12/31/1969
New York Total Medical Care PC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling, Phase III
Updated: 12/31/1969
Concord Repatriation General Hospital
mi
from
Concord,
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling, Phase III
Updated: 12/31/1969
OM Research LLC - Lancaster - ClinEdge - PPDS
mi
from
Lancaster, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling, Phase III
Updated: 12/31/1969
Atria Clinical Research - Interspond - PPDS
mi
from
Little Rock, AR
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Clinical research Network
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates of Hazard
mi
from
Hazard, KY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
CroNOLA, LLC
mi
from
Houma, LA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
Meridien Research - St. Petersburg- PPDS
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Avant Research Associates, LLC - Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Medical Research, LLC
mi
from
Beachwood, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastro Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastrointestinal Disease Research
mi
from
Columbus, GA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Northern Medical Group
mi
from
Fishkill, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates, PC
mi
from
Gainesville, VA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Research for Health Improvement, LLC
mi
from
Naples, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Advance Clinical Research - Dayton Internal Medicine
mi
from
Dayton, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Western Michigan University Homer Stryker MD School of Medicine
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid America Gastrointestinal Consultants
mi
from
Kansas City, MO
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Franciscan Skemp Healthcare
mi
from
La Crosse, WI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Precision Clinical Research
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Alliance Medical Research LLC
mi
from
Lighthouse Point, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Omega Research Maitland
mi
from
Orlando, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety of TD-1473 in Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety of TD-1473 in Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
Largo, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety of TD-1473 in Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Utah; Division of Gastroenterology/Hepatology
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Care Access Research
mi
from
San Pablo, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Peak Gastroenterology Associates
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Asthma and Allergy Associates PC - CRN
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alliance Medical Research LLC
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Consultants for Clinical Research
mi
from
Fairfield, OH
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
DelRicht Clinical Research, LLC - ClinEdge - PPDS
mi
from
New Orleans, LA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southtowns Gastroenterology, PLLC
mi
from
Orchard Park, NY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Minnesota Gastroenterology, P.A.
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates of West Michigan
mi
from
Wyoming, MI
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Trialspark, Inc.
mi
from
Astoria, NY
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Ventura Gastroenterolgy Medical Group
mi
from
Camarillo, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Peak Gastroenterology Associates
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Top Medical Research, Inc.
mi
from
Cutler Bay, FL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Illinois Gastroenterology Group
mi
from
Gurnee, IL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Centex Studies, Inc. - Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
TrialSpark
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Digestive Disease Specialists (DDSI)
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Klinikum Augsburg
mi
from
Augsburg,
Click here to add this to my saved trials
Hepatosplenic T-cell Lymphoma Clinical Trial
A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Thomas Jefferson University Ho
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Inverness, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
La Mirada, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Lima, OH
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Maitland, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Ocean Springs, MS
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Richland, WA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Stevensville, MI
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
West Monroe, LA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
West Valley City, UT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Wyoming, MI
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Flushing, NY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Kingsport, TN
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Madisonville, KY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Mexico, MO
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Asheville Gastroenterology Associates, P.A.; Gastroenterology
mi
from
Asheville, NC
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Digestive Disease Consultants - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
1 … 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24